OVARIAN CLEAR CELL ADENOCARCINOMA
Clinical trials for OVARIAN CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill target Hard-to-Treat ovarian cancers?
Disease control TerminatedThis early-stage trial is testing an experimental oral drug called NXP800 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find the safest dose and schedule, and then to see if the drug shows promise in specif…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Measles virus takes on ovarian cancer in early trial
Disease control TerminatedThis phase 2 trial tested a genetically modified measles virus (MV-NIS) against standard chemotherapy in 17 women with ovarian, fallopian, or peritoneal cancer that no longer responded to platinum drugs. The virus was designed to infect and kill cancer cells while leaving healthy…
Matched conditions: OVARIAN CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC